Second Price Monitoring Extn | 12-Oct-2022 | 16:41 | RNS |
Price Monitoring Extension | 12-Oct-2022 | 16:35 | RNS |
Clinical trial update | 12-Oct-2022 | 07:00 | RNS |
Second Price Monitoring Extn | 10-Oct-2022 | 11:05 | RNS |
Price Monitoring Extension | 10-Oct-2022 | 11:00 | RNS |
SFX-01 licensing deal for up to $160.5m | 10-Oct-2022 | 07:00 | RNS |
Regulatory approval for healthy volunteer study | 29-Sep-2022 | 07:00 | RNS |
Result of AGM | 22-Jul-2022 | 07:00 | RNS |
Investor Presentation | 14-Jul-2022 | 12:43 | RNS |
Notice of AGM | 06-Jul-2022 | 12:25 | RNS |
Collaboration with University of Michigan | 13-Jun-2022 | 07:00 | RNS |
Full Year Results | 08-Jun-2022 | 07:00 | RNS |
Notice of Results | 07-Jun-2022 | 07:00 | RNS |
Collaboration with Università Sapienza di R... | 25-May-2022 | 07:00 | RNS |
Holding(s) in Company | 29-Apr-2022 | 14:39 | RNS |
Currency | UK Pounds |
Share Price | 3.95p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 7.10 |
52 Week Low | 2.85 |
Volume | 250,175 |
Shares Issued | 274.89m |
Market Cap | £10.86m |
RiskGrade | 304 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
13:59 | 250,000 @ 3.93p |
13:39 | 75 @ 3.90p |
13:39 | 100 @ 4.00p |
CFO | Richard Moulson |
CEO | Huw Jones |
You are here: research